Mismatched human leukocyte antigen class II‐restricted CD8+ cytotoxic T cells may mediate selective graft‐versus‐leukemia effects following allogeneic hematopoietic cell transplantation

T. Hirosawa,H. Torikai,Mayumi Yanagisawa,M. Kamei,N. Imahashi,Ayako Demachi‐Okamura,M. Tanimoto,Keiko Shiraishi,Mamoru Ito,K. Miyamura,K. Shibata,F. Kikkawa,Y. Morishima,Toshitada Takahashi,N. Emi
DOI: https://doi.org/10.1111/j.1349-7006.2011.01949.x
IF: 5.7
2011-07-01
Cancer Science
Abstract:Partial human leukocyte antigen (HLA)‐mismatched hematopoietic stem cell transplantation (HSCT) is often performed when an HLA‐matched donor is not available. In these cases, CD8+ or CD4+ T cell responses are induced depending on the mismatched HLA class I or II allele(s). Herein, we report on an HLA‐DRB1*08:03‐restricted CD8+ CTL clone, named CTL‐1H8, isolated from a patient following an HLA‐DR‐mismatched HSCT from his brother. Lysis of a patient Epstein–Barr virus‐transformed B cell line (B‐LCL) by CTL‐1H8 was inhibited after the addition of blocking antibodies against HLA‐DR and CD8, whereas antibodies against pan‐HLA class I or CD4 had no effect. The 1H8‐CTL clone did not lyse the recipient dermal fibroblasts whose HLA‐DRB1*08:03 expression was upregulated after 1 week cytokine treatment. Engraftment of HLA‐DRB1*08:03‐positive primary leukemic stem cells in non‐obese diabetic/severe combined immunodeficient/γc‐null (NOG) mice was completely inhibited by the in vitro preincubation of cells with CTL‐1H8, suggesting that HLA‐DRB1*08:03 is expressed on leukemic stem cells. Finally, analysis of the precursor frequency of CD8+ CTL specific for recipient antigens in post‐HSCT peripheral blood T cells revealed a significant fraction of the total donor CTL responses towards the individual mismatched HLA‐DR antigen in two patients. These findings underscore unexpectedly significant CD8 T cell responses in the context of HLA class II. (Cancer Sci 2011; 102: 1281–1286)
What problem does this paper attempt to address?